People taking GLP-1 weight loss drugs like Ozempic started moving less

Article excerpt

People taking GLP-1 drugs like Ozempic and Wegovy are losing weight but moving significantly less, according to researchers who analyzed Fitbit data tracking daily step counts and exercise levels after medication started. The finding raises a paradox: while the drugs successfully shed pounds, they may simultaneously strip away muscle mass along with fat. The decline in physical activity could undermine long-term health and strength, suggesting that weight loss alone may not tell the full story of these drugs' effects on the body.